Marshall Wace, LLP GW PHARM-ADR Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
N/A
-85,060 Closed
0 $0
Q1 2021

May 17, 2021
BUY
N/A
85,060 New
85,060 $18.4 Million
Q3 2020

Nov 16, 2020
SELL
N/A
-23,833 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
N/A
18,620 Added 357.18%
23,833 $2.93 Million
Q1 2020

May 15, 2020
BUY
N/A
2,258 Added 76.41%
5,213 $457,000
Q4 2019

Feb 14, 2020
SELL
N/A
-45,672 Reduced 93.92%
2,955 $309,000
Q3 2019

Nov 14, 2019
BUY
N/A
41,908 Added 623.72%
48,627 $5.59 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-5,147 Reduced 43.38%
6,719 $1.16 Million
Q1 2019

May 14, 2019
BUY
N/A
7,568 Added 176.08%
11,866 $2 Million
Q4 2018

Feb 14, 2019
BUY
N/A
4,298 New
4,298 $419,000
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email